Trial intelligence / Profile preview

Duloxetine for Post-Laparoscopic Shoulder Pain

NCT03249168Phase 3Completed

Sponsor
Assiut University
Start
Oct 2017
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in shoulder pain comparing Duloxetine Group with Placebo Group (2 arms). Primary endpoint: Post-laparoscopic shoulder pain at 12 hours. Started Oct 2017; status: completed.

02

Drugs

duloxetine
03

Conditions

shoulder pain

Beyond the preview

Go deeper on NCT03249168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03249168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call